Advances in organ preservation techniques and future prospects

Ab­b­Vie rolled out a new sto­ry­telling strat­e­gy on Tues­day fo­cused on re­search and de­vel­op­ment that it calls “The Case for Big Bets.” An in­tro­duc­to­ry video

Verve Ther­a­peu­tics is paus­ing work on its lead gene edit­ing treat­ment, which was the first time base edit­ing was used to di­rect­ly al­ter DNA in